Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, making it fundamental to medical research. As assays evolve to capture more ...
KCAS Bio, a global provider of harmonized spectral flow cytometry, today announced ongoing developments in its service ...
Tempus AI, Inc. and Predicta Biosciences recently expanded the commercial rollout of their co-branded GenoPredicta™ whole-genome sequencing assay, which combines flow cytometry and ultra-sensitive ...
Ardena opens bioanalytical lab in Somerset to support client studies, strengthen precision medicine development: Somerset, New Jersey Thursday, April 16, 2026, 18:00 Hrs [IST] Ard ...
TEM expands GenoPredicta rollout and deepens oncology partnerships, leveraging AI and WGS to advance cancer diagnostics and ...
The Somerset site, acquired by Ardena in 2025, includes an FDA-approved facility for advanced drug product manufacturing supporting clinical development and commercial supply. Combined with Ardena's ...
At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...
In this webinar, Zivjena Vucetic will discuss how single-cell sequencing improves measurable residual disease detection (MRD) ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results